RecruitingNCT05962892

A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma


Sponsor

Beijing Friendship Hospital

Enrollment

600 participants

Start Date

Feb 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

A prospective cohort of papillary thyroid carcinoma(PTC), patients who received thermal ablation in our hospital since February 2023 was established as the study object. Preoperative and postoperative demographic data, ultrasonography, other relevant laboratory tests, and thyroid disease-related scales such as fatigue, depression, and stress were collected. The influencing factors of PTC recurrence were analyzed.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at why some small papillary thyroid cancers (a common, slow-growing type of thyroid cancer, 1 cm or smaller) come back after being treated with a minimally invasive procedure called thermal ablation, which uses heat to destroy the tumor without surgery. **You may be eligible if...** - You are 18 or older - You have a single papillary thyroid carcinoma that is 1 cm or smaller and at least 2 mm from the thyroid capsule - Ultrasound confirms no spread to lymph nodes or other areas - Your cancer has been confirmed by biopsy - You consent to have the thermal ablation procedure **You may NOT be eligible if...** - You have multiple cancerous nodules - Your tumor is larger than 1 cm or too close to the edge of the thyroid - There is evidence of spread beyond the thyroid gland - You are not a candidate for thermal ablation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo Intervention

No Intervention


Locations(1)

Beijing Friendship Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05962892


Related Trials